Successful treatment and remission of advanced testicular cancer after COVID-19 infection during induction chemotherapy.
IJU Case Rep
; 7(4): 289-292, 2024 Jul.
Article
en En
| MEDLINE
| ID: mdl-38966772
ABSTRACT
Introduction:
We report a case of advanced testicular cancer cured by early and appropriate resumption of chemotherapy even after COVID-19 infection during induction chemotherapy. Case presentation The patient was a healthy 36-year-old male. The diagnosis was a stage IIIB nonseminoma (pT2N2M1a). On day 14 of the first chemotherapy cycle, the patient was diagnosed with mild COVID-19. The second chemotherapy cycle was initiated with a 1-day delay (on day 10 after the COVID-19 diagnosis). The patient achieved remission with minimal postponement of chemotherapy.Conclusion:
Only a few case reports have described the resumption of anticancer chemotherapy in patients with COVID-19. In deciding when to resume chemotherapy after COVID-19 infection, it is essential to consider factors such as cancer type, progression, and severity of COVID-19 and should be tailored to individual patient needs.
Texto completo:
1
Colección:
01-internacional
Idioma:
En
Revista:
IJU Case Rep
Año:
2024
Tipo del documento:
Article